Updates

Date: 11 August 2026 Ref. No.: TCPCL/SEC/2026-27/00035 The General Manager, The Manager, Corporate relationship department, Listing department, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Fort, Bandra-Kurla Complex, Bandra(E), Mumbai-400 001 Mumbai-400 051 Scrip Code: 543321 Scrip Symbol: TATVA Subject: Communication to Shareholders – Final Dividend for FY 2025-26 - Intimation on Tax Deduction at source (TDS) / withholding tax on Dividend Dear Sir/Madam, Pursuant to provisions of the Income-tax Act, 2025, dividend income is taxable in the hands of the shareholders. In this regard, please find enclosed herewith an email communication which has been sent to all the shareholders having their email ID's registered with the Company / Registrar and Transfer Agent / Depositories explaining the process and documentation required for claiming tax exemption / withholding tax on dividend payable to the Shareholders at prescribed rates. The above information shall be made available on the website of the Company at www.tatvachintan.com. You are requested to take the same on your records. Thanking you, Yours faithfully, For Tatva Chintan Pharma Chem Limited Ishwar Nayi Company Secretary and Compliance Officer M. No.: A37444 Encl.: As above Tatva Chintan Pharma Chem Limited CIN: L24232GJ1996PLC029894 Registered Office and Factory: Plot No. 502/17, GIDC Estate, Ankleshwar – 393 002, District: Bharuch, Gujarat, India. Dahej SEZ Unit: Plot No. Z/103/F/1 & 2, SEZ Area, Part-2, Dahej – 392 130, District: Bharuch, Gujarat, India. Corporate Office and R & D Center (DSIR Approved): Plot No. 353, GIDC, Makarpura, Vadodara – 390 010, Gujarat, India. Tel. No.: +91 75748 48533 / 34 I Fax: +91 265 263 8533 I E-mail: cs@tatvachintan.com | Website: www.tatvachintan.com Date: 11/08/2026 Subject: Communication of deduction of tax at source on Dividend Dear Shareholder, We wish to inform you that the Board of Directors (“the Board”) of Tatva Chintan Pharma Chem Limited (“the Company”) in their meeting held on 16 May 2026 had recommended final dividend of Rs. 2.00/- (i.e. 20%) per equity share having face value of Rs. 10/- each for the financial year ended 31 March 2026. The dividend, as recommended by the Board, if approved by the shareholders at the ensuing 30th Annual General Meeting (“AGM”), will be paid to those shareholders holding equity shares of the Company as on Record Date. Pursuant to implementation of the Income-tax Act, 2025, (“the Act”), dividend paid or distributed by a Company is taxable in the hands of the shareholders. The Company shall therefore be required to deduct tax at source before making distribution or at the time of payment of dividend. The deduction of tax at source will be based on the category of shareholders and subject to fulfilment of conditions as provided herein below: For resident shareholders Tax will be deducted at source (“TDS”) under Section 393(1) [Table: Sl. No. 7] read with 393(4) [Table Sl. No. 10] of the Act @ 10% on the amount of dividend payable unless exempt under any of the provisions of the Act. However, in case of resident individuals, TDS would not apply if the aggregate of total dividend payable to the resident individual shareholder by the Company during Tax Year does not exceed Rs. 10,000/-. Tax at source will not be deducted in cases where a shareholder provides Form 121, provided that the eligibility conditions are being met. Blank Form 121 can be downloaded from the link given at the end of this communication. Please note that all fields mentioned in the Form are mandatory and Company may reject the forms submitted, if it does not fulfil the requirement of law. In case, shareholders have invalid PAN / PAN not linked with Aadhaar / not registered their valid PAN details in their account or classified as specified person in the income tax portal / do not have PAN, TDS at the rate of 20% shall be deducted under Section 397(2)(b)(i) of the Act. NIL / lower tax shall be deducted on the dividend payable to following resident shareholders on submission of self-declaration (as per format attached) as listed below: i. Insurance companies: Declaration (refer format) by shareholder qualifying as Insurer as per Section 2(7A) of the Insurance Act, 1938 along with self-attested copy of PAN card and certificate of registration with Insurance Regulatory and Development Authority of India (IRDAI)/LIC/GIC; ii. Mutual Funds: Declaration (refer format) by Mutual Fund shareholder as specified at schedule VII (Table: SI. No. 20 or 21) to Section 11 of the Act, along with self-attested copies of registration documents and PAN card; iii. Alternative Investment Fund (AIF) established in India: Declaration (refer format) by Alternative Investment Fund shareholder as specified at schedule V (Table: SI. No. 1) to Section 11 of the Act and they are established as Category I or Category II AIF under the SEBI regulations. Copy of self-attested registration documents and PAN card should be provided; iv. New Pension System Trust: Declaration (refer format) along with self-attested copy of documentary evidence supporting the exemption and self-attested copy of PAN card; v. Other shareholders – Declaration (refer format) along with self-attested copy of documentary evidence supporting the exemption and self-attested copy of PAN card; vi. Shareholders who have provided a valid certificate issued u/s. 395(1) of the Act for lower / NIL rate of deduction or an exemption certificate issued by the income tax authorities along with Declaration (refer format). For non-resident shareholders (including Foreign Institutional Investors and Foreign Portfolio Investors) Tax is required to be withheld in accordance with the provisions of Section 393(2) [Table Sl. No 17] read with section 207(1) [Table Sl. No. 1] of the Act at applicable rates in force. As per the relevant provisions of the Act, the tax shall be withheld @ 20% (plus applicable surcharge and cess) on the amount of dividend payable. In case non-resident shareholders provide a certificate issued under Section 395(1) of the Act, for lower / NIL withholding taxes, rate specified in the said certificate shall be considered, on submission of self-attested copy of the same. However, as per Section 159 of the Act, a non-resident shareholder has the option to be governed by the provisions of the Double Tax Avoidance Agreement (“DTAA”) between India and the country of tax residence of the shareholder, if they are more beneficial to the shareholder. For this purpose, i.e. to avail the tax treaty benefits, the non-resident shareholder will have to provide the following: i. Self-attested copy of PAN card, if any, allotted by the Indian income tax authorities; In case PAN is not available, the non-resident shareholder shall furnish (a) name, (b) e- mail ID, (c) contact number, (d) address in residency country, (e) Tax Identification Number of the residency country (link of format attached); ii. Self-attested copy of Tax Residency Certificate (“TRC”) (Tax year 2026-27 obtained from the tax authorities of the country of which the shareholder is resident; iii. For shareholders who proposes to claim treaty benefit, they need to Form no. 41 shall be furnished online at the link https://www.incometax.gov.in/iec/foportal/ to avail the benefit of DTAA; iv. Self-declaration (refer format) by the non-resident shareholder for the period 01 April 2026 to 31 March 2027 of having no Permanent Establishment in India in accordance with the applicable Tax treaty; v. In case of Foreign Institutional Investors and Foreign Portfolio Investors, self-attested copy of SEBI registration certificate; vi. In case of shareholder being tax resident of Singapore, please furnish the letter issued by the competent authority or any other evidences demonstrating the non-applicability of Article 24 - Limitation of Relief under India-Singapore Double Taxation Avoidance Agree [Showing first 8,000 characters — download PDF for full document]